Reportlinker.com

Reportlinker.com

July 02, 2008 05:50 ET

High Growth Reported for the World Smoking Cessation Aids Market

LONDON, UNITED KINGDOM--(Marketwire - July 2, 2008) - Reportlinker.com announces that a new market research report related to the Personal care industry is available in its catalogue.

World Smoking Cessation Aids Market

http://www.reportlinker.com/p090576/World-Smoking-Cessation-Aids-Market.html

This report analyzes the worldwide markets for Smoking Cessation Aids in US$ Million. The major product segments analyzed are Nicotine Gum, Nicotine Patch, Nicotine lozenges & tablets, and Others (Nicotine Inhaler, and Nasal Spray). The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 32 companies including many key and niche players worldwide such as GlaxoSmithKline Plc, Johnson & Johnson Inc., Novartis Consumer Healthcare Inc., Perrigo Company, and Pfizer Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.


SMOKING CESSATION AIDS MCP-1591 
A GLOBAL STRATEGIC BUSINESS REPORT 


CONTENTS 


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 

Study Reliability and Reporting Limitations I-1 
Disclaimers I-2 
Data Interpretation & Reporting Level I-2 
Quantitative Techniques & Analytics I-2 
Product Definition and Scope of Study I-3 
Smoking Cessation Aids I-3 
Definitions I-3 
A. Nicotine Gum I-3 
B. Nicotine Patch I-4 
C. Nicotine Lozenges And Tablets I-4 
D. Others I-4 
Nicotine Inhaler I-4 
Nicotine Nasal Spray I-4 


II. EXECUTIVE SUMMARY 

1. Industry Outlook II-1 
Leading Players II-1 
Tobacco Products Industry: An Introduction II-1 
Regulations/Taxes II-2 
Black Market II-2 
Cigarette: The Tobacco King II-3 
Cigars: All Rolled Up II-3 
Glut of Products Restrain Growth II-3 
Major Cigar Tobacco Producing Regions II-3 
China Dominates the Cigarettes Sector II-4 
Competitive Scenario II-4 
Table 1: World Cigarettes Market for 2004 & 2005: Market 
Shares Based on Volume Sales of Leading Manufacturers for 
Philip Morris, British American Tobacco, Japan Tobacco, 
Imperial Tobacco, Gallaher, Reynolds American and Others 
(includes corresponding Graph/Chart) II-4 

Table 2: World Recent Past, Current & Future Analysis for 
Cigarettes by Geographic Region - US, Canada, Japan, Europe, 
Asia-Pacific (excluding Japan), Latin America and Rest of 
World Markets Independently Analyzed with Annual Sales 
Figures in Billion Units for Years 2000 2006 and 2010 
(includes corresponding Graph/Chart) II-5 

Table 3: World Recent Past, Current & Future Analysis for 
Cigars by Geographic Region - US, Canada, Japan, Europe, 
Asia-Pacific (excluding Japan), Latin America and Rest of 
World Markets Independently Analyzed with Annual Sales 
Figures in Million Units for Years 2000 2006 and 2010 
(includes corresponding Graph/Chart) II-5 

Table 4: World Recent Past, Current & Future Analysis for 
Cigarettes by Geographic Region - US, Canada, Japan, 
Europe, Asia-Pacific (excluding Japan), Latin America and 
Rest of World Markets Independently Analyzed with Annual 
Sales Figures in US$ Billion for Years 2000 2006 and 2010 
(includes corresponding Graph/Chart) II-6 

Table 5: World Recent Past, Current & Future Analysis for 
Cigars by Geographic Region - US, Canada, Japan, Europe, 
Asia-Pacific (excluding Japan), Latin America and Rest of 
World Markets Independently Analyzed with Annual Sales 
Figures in US$ Million for Years 2000, 2006 and 2010 
(includes corresponding Graph/Chart) II-6 
Why to Quit Smoking II-7 
Secondhand Smoke II-7 
Why Smoking is Hard to Quit II-7 
Methods of Smoking Cessations II-8 
Cold Turkey II-8 
Drug Therapies II-9 
Other Interventions II-9 
Benefits of Quitting Smoking II-9 

2. World Smoking Statistics II-11 

3. Product Overview II-12 
Smoking Cessation Aids Defined II-12 
Nicotine Gum II-12 
Factors to Consider II-12 
Effectiveness of Nicotine Gum II-13 
Nicotine Patch II-13 
Factors to Consider II-14 
Nicotine Lozenges & Tablets II-14 
Factors to Consider II-15 
Other Smoking Cessation Aids II-15 
Nicotine Inhaler II-15 
Factors to Consider II-15 
Nicotine Nasal Spray II-16 
Factors to Consider II-16 
Non-Nicotine Based Medications II-16 

4. Trends and Issues II-17 
Inundate Anti-Smoking Vaccines Kindles Underdeveloped 
Prescription Market II-17 
Strict Regulations Deter Smoking Cessation Aids II-17 
Growing Anti Smoking Campaigns II-18 
Health Concerns II-18 
Corporations Initiate for Smoke Free Work Environment II-18 
Television Advertisements - Most Effective Media for Smoking 
Cessation II-19 
Public Awareness through Internet II-19 
Rising Prices of Tobacco - A Key Strategy for Quitting Smoking II-19 

5. Product Innovations/Introductions II-20 
Acomplia to Enter Smoking Cessation Market II-20 
Fertin Phiarma and Perrigo to Launch Nicotine Gum in the US 
Market II-20 
Nicodrops Unveils New Lozenge for Smoking Cessation II-20 
Pharmacia and Takeda to Launch Smoking Cessation Aid in Japan II-20 
Glaxo Unveils First Anti-Smoking Medicine in India II-20 

6. Recent Industry Activity II-21 
Pfizer Japan to Roll Out Champix Anti-Smoking Drug II-21 
Inverness Medical Innovations Pockets Bio-Stat Healthcare Group II-21 
Novartis New Smoking Cessation Aids Gets FDA's Approval II-21 
Johnson & Johnson Concludes Take Over of Pfizer Consumer 
Healthcare II-21 
Pfizer Receives FDA Approval for Smoking Cessation Medicine 
Chantix(TM) II-22 
Perrigo Obtains FDA Approval to Sell Coated Nicotine Gum II-22 
Pfizer Receives Chinese Approval for Clinical Trials on 
Smoking Cessation Aid II-22 
Pfizer Receives EC Approval for New Varenicline II-22 
Formation of Sanofi-Aventis II-22 
AXIA Health Management Acquires Smoking Cessation Website II-23 
Nicodrops Receives EC Approval for Smoking Cessation Aid II-23 
Nabi Unveils Successful Phase II Results for Smoking 
Cessation Vaccine II-23 
FDA Grants Approval for High Strength Bupropion II-23 
Watson Pharmaceuticals Receives Rights to Market Zyban(R) II-24 
Pfizer Merges with Pharmacia II-24 
FDA Approves Anti-Smoking Medication for OTC Sales II-24 
GSK and Taisho to Develop Anti-Smoking Medication II-24 
Johnson & Johnson Acquires Alza II-24 

7. Focus on Select Global Players II-25 
GlaxoSmithKline Plc (UK) II-25 
Johnson & Johnson Inc. (USA) II-25 
Novartis Consumer Healthcare Inc. (USA) II-25 
Perrigo Company (USA) II-26 
Pfizer Inc. (USA) II-26 

8. Global Market Perspective II-27 
Table 6: World Recent Past, Current & Future Analysis for 
Smoking Cessation Aids by Geographic Region - US, Canada, 
Europe and Rest of World Independently Analyzed by Annual 
Sales in US$ Million for the Years 2000 through 2010 
(includes corresponding Graph/Chart) II-27 

Table 7: World Long Term Projections for Smoking Cessation 
Aids by Geographic Region - US, Canada, Europe and Rest of 
World Independently Analyzed by Annual Sales in US$ Million 
for the Years 2011 through 2015 (includes corresponding 
Graph/Chart) II-28 

Table 8: World 10-Year Perspective for Smoking Cessation Aids 
by Geographic Region - Percentage Break down of Dollar Sales 
for US, Canada, Europe and Rest of the World for the Years 
2003, 2008 and 2012 (includes corresponding Graph/Chart) II-29 


III. MARKET 

1. The United States III-1 
A.Market Analysis III-1 
Outlook III-1 
Cigarette Smoking Decline Stagnates in the US III-1 
Smoking Women are at High Risk III-1 
Tobacco Companies Spend Big on Advertising III-1 
NRT - A Peer into the Past III-1 
Popular NRT Brands in the US Market III-2 
Key Statistics: III-2 
Table 9: Top 4 Nicotine Chewing Gum Brands in the US: 
Breakdown of Dollar Sales Through Supermarkets, Drug Stores & 
Discount Stores for the Year Ended November 2007 (In US$ 
000) III-2 

Table 10: US Market for Smoking Cessation Products: 
Percentage Share Breakdown of Value and Volume Sales by 
Product Category - Gum, Patch, Tablets, and Others (incl. 
Mouth Spray, Filters) for the Year Ended November 2007 
(includes corresponding Graph/Chart) III-3 

Table 11: Leading NRT Brands in the US Market by Product 
Type in 2005: Sales in US$ Millions for Nicorette, Nicoderm 
CQ, Commit and Other Brands & Private Labels (includes 
corresponding Graph/Chart) III-3 
Product Launches/Developments III-4 
Strategic Corporate Developments III-4 
Key Players III-6 
B.Market Analytics III-9 
Table 12: US Recent Past, Current & Future Analysis for 
Smoking Cessation Aids by Product Segment - Nicotine Gum, 
Nicotine Patches and Lozenges & Tablets Independently 
Analyzed by Annual Sales in US$ Million for the Years 2000 
through 2010 (includes corresponding Graph/Chart) III-9 

Table 13: US Long Term Projections for Smoking Cessation 
Aids by Product Segment - Nicotine Gum, Nicotine Patches 
and Lozenges & Tablets Independently Analyzed by Annual 
Sales in US$ Million for the Years 2011 through 2015 
(includes corresponding Graph/Chart) III-9 

Table 14: US 10-Year Perspective for Smoking Cessation Aids 
by Product Segment - Percentage Breakdown of Dollar Sales 
for Nicotine Gum, Nicotine Patches and Lozenges & Tablets 
for the Years 2003, 2008 and 2012 (includes corresponding 
Graph/Chart) III-10 

2. Canada III-11 
A.Market Analysis III-11 
Outlook III-11 
B.Market Analytics III-11 
Table 15: Canadian Recent Past, Current & Future Analysis 
for Smoking Cessation Aids by Product Segment - Nicotine 
Gum, Nicotine Patches and Lozenges & Tablets Independently 
Analyzed by Annual Sales in US$ Million for the Years 2000 
through 2010 (includes corresponding Graph/Chart) III-11 

Table 16: Canadian Long Term Projections for Smoking 
Cessation Aids by Product Segment - Nicotine Gum, Nicotine 
Patches and Lozenges & Tablets Independently Analyzed by 
Annual Sales in US$ Million for the Years 2011 through 2015 
(includes corresponding Graph/Chart) III-12 

Table 17: Canadian 10-Year Perspective for Smoking Cessation 
aids by Product Segment - Percentage Breakdown of Dollar 
Sales for Nicotine Gum, Nicotine Patches and Lozenges & 
Tablets for the Years 2003, 2008 & 2012 (includes 
corresponding Graph/Chart) III-12 

3. Europe III-13 
A.Market Analysis III-13 
Outlook III-13 
Strategic Corporate Developments III-13 
Key Players III-14 
B.Market Analytics III-16 
Table 18: European Recent Past, Current & Future Analysis 
for Smoking Cessation Aids by Geographic Region - France, 
Germany, UK, Italy, Spain & Rest of Europe Independently 
Analyzed by Annual Sales in US$ Million for the Years 2000 
through 2010 (includes corresponding Graph/Chart) III-16 

Table 19: European Long Term Projections for Smoking 
Cessation Aids by Geographic Region - France, Germany, UK, 
Italy, Spain & Rest of Europe Independently Analyzed by 
Annual Sales in US$ Million for the Years 2011 through 2015 
(includes corresponding Graph/Chart) III-17 

Table 20: European Recent Past, Current & Future Analysis 
for Smoking Cessation Aids by Product Segment - Nicotine 
Gum, Nicotine Patches, Lozenges & Tablets and Others 
Independently Analyzed by Annual Sales in US$ Million for 
the Years 2000 through 2010 (includes corresponding 
Graph/Chart) III-18 

Table 21: European Long Term Projections for Smoking 
Cessation Aids by Product Segment - Nicotine Gum, Nicotine 
Patches, Lozenges & Tablets and Others Independently 
Analyzed by Annual Sales in US$ Million for the Years 2011 
through 2015 (includes corresponding Graph/Chart) III-18 

Table 22: European 10-Year Perspective for Smoking Cessation 
Aids by Geographic Region - Percentage Breakdown of Dollar 
Sales for France, Germany, UK, Italy, Spain, Russia and Rest 
of Europe for the Years 2003, 2008 & 2012 (includes 
corresponding Graph/Chart) III-19 

Table 23: European 10-Year Perspective for Smoking Cessation 
Aids by Product Segment - Percentage Breakdown of Dollar 
Sales for Nicotine Gum, Nicotine Patches, Lozenges & 
Tablets and Others for the Years 2003, 2008 & 2012 
(includes corresponding Graph/Chart) III-19 

3a. France III-20 
A.Market Analysis III-20 
Outlook III-20 
B.Market Analytics III-20 
Table 24: French Recent Past, Current & Future Analysis for 
Smoking Cessation Aids by Product Segment - Nicotine Gum, 
Nicotine Patches, Lozenges & Tablets and Others 
Independently Analyzed by Annual Sales Figures in US$ 
Million for the Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-20 

Table 25: French Long Term Projections for Smoking Cessation 
Aids by Product Segment - Nicotine Gum, Nicotine Patches, 
Lozenges & Tablets, and Others Independently Analyzed by 
Annual Sales in US$ Million for the Years 2011 through 2015 
(includes corresponding Graph/Chart) III-21 

Table 26: French 10-Year Perspective for Smoking Cessation 
Aids by Product Segment - Percentage Breakdown of Dollar 
Sales for Nicotine Gum, Nicotine Patches, Lozenges & 
Tablets, and Others for the Years 2003, 2008 and 2012 
(includes corresponding Graph/Chart) III-21 

3b. Germany III-22 
A.Market Analysis III-22 
Outlook III-22 
B.Market Analytics III-22 
Table 27: German Recent Past, Current & Future Analysis for 
Smoking Cessation aids by Product Segment - Nicotine Gum, 
Nicotine Patches, Lozenges & Tablets, and Other Markets 
Independently Analyzed with Annual Sales Figures in US$ 
Million for Years 2000 through 2010 (includes corresponding 
Graph/Chart) III-22 

Table 28: German Long Term Projections for Smoking Cessation 
Aids by Product Segment - Nicotine Gum, Nicotine Patches, 
Lozenges & Tablets, and Others Independently Analyzed by 
Annual Sales in US$ Million for the Years 2011 through 2015 
(includes corresponding Graph/Chart) III-23 

Table 29: German 10-Year Perspective for Smoking Cessation 
aids by Product Segment - Percentage Breakdown of Value 
Sales for Nicotine Gum, Nicotine Patches, Lozenges & 
Tablets, and Other Markets for 2003, 2008 and 2012 
(includes corresponding Graph/Chart) III-23 

3c. The United Kingdom III-24 
A.Market Analysis III-24 
Outlook III-24 
Table 30: Leading OTC-NRT Brands by Company in the UK in 
2005: Percentage Breakdown of Value Sales for Nicorette, 
Niquitin CQ, Nicotinell and Others (includes corresponding 
Graph/Chart) III-24 

Table 31: NRT Advertisement Expenditure by Leading 
Companies in the UK in 2005: Percentage Breakdown for 
Pfizer, GlaxoSmithKline, Novartis and Others (includes 
corresponding Graph/Chart) III-24 
B.Market Analytics III-25 
Table 32: UK Recent Past, Current & Future Analysis for 
Smoking Cessation Aids by Product Segment - Nicotine Gum, 
Nicotine Patches, Lozenges & Tablets and Others 
Independently Analyzed by Annual Sales in US$ Million for 
the Years 2000 through 2010 (includes corresponding 
Graph/Chart) III-25 

Table 33: UK Long Term Projections for Smoking Cessation 
Aids by Product Segment - Nicotine Gum, Nicotine Patches, 
Lozenges & Tablets, and Others Independently Analyzed by 
Annual Sales in US$ Million for the Years 2011 through 2015 
(includes corresponding Graph/Chart) III-26 

Table 34: UK 10-Year Perspective for Smoking Cessation Aids 
by Product Segment - Percentage Breakdown of Dollar Sales 
for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and 
Others for the Years 2003,2008 and 2012 (includes 
corresponding Graph/Chart) III-26 

3d. Italy III-27 
A.Market Analysis III-27 
Outlook III-27 
B.Market Analytics III-27 
Table 35: Italian Recent Past, Current & Future Analysis for 
Smoking Cessation Aids by Product Segment - Nicotine Gum, 
Nicotine Patches, Lozenges and Tablets and Others 
Independently Analyzed by Annual Sales in US$ Million for 
the Years 2000 through 2010 (includes corresponding 
Graph/Chart) III-27 

Table 36: Italian Long Term Projections for Smoking 
Cessation Aids by Product Segment - Nicotine Gum, Nicotine 
Patches, Lozenges & Tablets, and Others Independently 
Analyzed by Annual Sales in US$ Million for the Years 2011 
through 2015 (includes corresponding Graph/Chart) III-28 

Table 37: Italian 10-Year Perspective for Smoking Cessation 
Aids by Product Segment - Percentage Breakdown of Dollar 
Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets 
and Others for the Years 2003, 2008 and 2012 (includes 
corresponding Graph/Chart) III-28 

3e. Spain III-29 
A.Market Analysis III-29 
Outlook III-29 
B.Market Analytics III-29 
Table 38: Spanish Recent Past, Current & Future Analysis 
for Smoking Cessation Aids by Product Segment - Nicotine 
Gum, Nicotine Patches, Lozenges & Tablets and Others 
Independently Analyzed by Annual Sales in US$ Million for 
the Years 2000 through 2010 (includes corresponding 
Graph/Chart) III-29 

Table 39: Spanish Long Term Projections for Smoking 
Cessation Aids by Product Segment - Nicotine Gum, Nicotine 
Patches, Lozenges & Tablets, and Others Independently 
Analyzed by Annual Sales in US$ Million for the Years 2011 
through 2015 (includes corresponding Graph/Chart) III-30 

Table 40: Spanish 10-Year Perspective for Smoking Cessation 
Aids by Product Segment - Percentage Breakdown of Dollar 
Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets 
and Others for the Years 2003, 2008 and 2012 (includes 
corresponding Graph/Chart) III-30 

3f. Rest of Europe III-31 
A.Market Analysis III-31 
Outlook III-31 
B.Market Analytics III-31 
Table 41: Rest of Europe Recent Past, Current & Future 
Analysis for Smoking Cessation Aids by Product Segment - 
Nicotine Gum, Nicotine Patches, Lozenges & Tablets and 
Others Independently Analyzed by Annual Sales in US$ Million 
for the Years 2000 through 2010 (includes corresponding 
Graph/Chart) III-31 

Table 42: Rest of Europe Long Term Projections for Smoking 
Cessation Aids by Product Segment - Nicotine Gum, Nicotine 
Patches, Lozenges & Tablets, and Others Independently 
Analyzed by Annual Sales in US$ Million for the Years 2011 
through 2015 (includes corresponding Graph/Chart) III-32 

Table 43: Rest of Europe 10-Year Perspective for Smoking 
Cessation Aids by Product Segment - Percentage Breakdown of 
Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & 
Tablets and Others for the Years 2003, 2008 and 2012 
(includes corresponding Graph/Chart) III-32 

4. Rest of World III-33 
A.Market Analysis III-33 
Outlook III-33 
Smoking Statistics in China III-33 
Barriers to Promote Smoking Cessation in the Developing World III-33 
Economic Factors III-33 
Inadequate Policies to Support Cessation III-33 
Low Perception of Risk among Public and Policy Makers III-34 
Poor Healthcare Systems and Infrastructure III-34 
Lack of Technology III-34 
Strategic Corporate Developments III-34 
Product Launches III-35 
B.Market Analytics III-36 
Table 44: Rest of World Recent Past, Current & Future 
Analysis for Smoking Cessation Aids - Annual Sales in US$ 
Million for the Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-36 

Table 45: Rest of World Long Term Projections for Smoking 
Cessation Aids - Annual Sales in US$ Million for the Years 
2011 through 2015 (includes corresponding Graph/Chart) III-36 


IV. COMPETITIVE LANDSCAPE

To order this report:

World Smoking Cessation Aids Market

http://www.reportlinker.com/p090576/World-Smoking-Cessation-Aids-Market.html

More market research reports here!

Contact Information